COMP <GO>
CDNA vs BLLN // ENTERPRISE SCALE & MARKET CAP
CareDx Inc. (NASDAQ) VS. BillionToOne Inc. (NASDAQ) • 15-METRIC TALLY: CDNA 3
— BLLN 7
▲ ENTERPRISE SCALE & MARKET CAP LEADER: BLLN
LAST: $85.88 (-1.75%) • MKT CAP: $4.59B
market-cap
$4.59B
LAST: $110.41 (-2.57%) • MKT CAP: $5.35B
market-cap
$5.35B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CDNA VS. BLLN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CDNA | BLLN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 68.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -8.20% | 2.90% | -11.10 | BLLN | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 95.0x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.67% | 0.29% | +0.38 | CDNA | /fcf-yield <GO> |
| Operating Margin | -8.10% | 5.30% | -13.40 | BLLN | /operating-margins <GO> |
| Net Profit Margin | -5.60% | 2.40% | -8.00 | BLLN | /net-margins <GO> |
| Revenue Growth (YoY) | 13.80% | 100.00% | -86.20 | BLLN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 19.22 | 22.24 | -3.02 | BLLN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | BLLN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.4 | 58.4 | +9.00 | CDNA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.06 | 1.02 | +0.04 | CDNA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.0x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $4.59B | $5.35B | -$754.5M | BLLN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CDNA REV | BLLN REV | CDNA GROSS % | BLLN GROSS % | CDNA FCF | BLLN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $379.8M | $305.1M | — | 68.3% | $24.9M | $15.7M |
| FY 2024 | $333.8M | $152.6M | — | 53.0% | $23.0M | -$46.8M |
| FY 2023 | $280.3M | $71.7M | — | — | -$31.0M | -$56.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CDNA // BETA 1.06
BLLN // BETA 1.02